Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits-Reference-Cited by-同舟云学术

Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits

Published:2018-12 Issue: Volume:62 Page:24-29
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Folch Cinta,Lorente Nicolas,Majó Xavier,Parés-Badell Oleguer,Roca Xavier,Brugal Teresa,Roux Perrine^ORCID,Carrieri Patrizia^ORCID,Colom Joan,Casabona Jordi

Funder

Agència de Salut Pública de Catalunya

Departament de Salut

Generalitat de Catalunya

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference22 articles.

1. Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification;Amato;Cochrane Database of Systematic Reviews,2008

2. Barcelona’s safer injection facility – EVA: A harm reduction program lacking official support;Anoro;Journal of Drug Issues,2003

3. Use of supervised injection facilities and injection risk behaviours among young drug injectors;Bravo;Addiction (Abingdon, England),2009

4. Sistema Integrat de Vigilància Epidemiològica de la SIDA/VIH/ITS a Catalunya;Centre d’Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT),2015

5. Injecting and HIV prevalence among young heroin users in three Spanish cities and their association with the delayed implementation of harm reduction programmes;de la Fuente;Journal of Epidemiology and Community Health,2006

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healthcare providers’ knowledge and attitudes about overdose prevention sites in Colorado;Harm Reduction Journal;2024-08-24

2. Overdose prevention centres as spaces of safety, trust and inclusion: A causal pathway based on a realist review;Drug and Alcohol Review;2024-08-05

3. In Support of Overdose Prevention Centers: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education and Research in Substance Use and Addiction);Substance Use & Addiction Journal;2024-05-15

4. Barriers to access to hepatitis C treatment with direct-acting antivirals in people who inject drugs in the community setting;Harm Reduction Journal;2024-04-27

5. All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019;International Journal of Drug Policy;2024-02